0 Commentarii
0 Distribuiri
190 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period Attaining...0 Commentarii 0 Distribuiri 305 Views 0 previzualizare
-
Obesity and Metabolic Disorder Wearables Market Size,Trends And Analysis 2032According to the latest report published by Data Bridge Market Research, the Obesity and Metabolic Disorder Wearables Market The global Obesity & Metabolic Disorder Wearables Market size was valued at USD 7.48 billion in 2025 and is expected to reach USD 18.92 billion by 2033, at a CAGR of 12.3% during the forecast period This Obesity and Metabolic...0 Commentarii 0 Distribuiri 143 Views 0 previzualizare
-
Anorexiants Market Driven by Rising Obesity Treatment DemandThe rising global burden of obesity has significantly increased the demand for appetite suppressant drugs, advanced weight loss medications, and modern anti-obesity drugs. These therapies are now a central part of medical weight management strategies as healthcare systems attempt to address obesity-related complications such as diabetes, cardiovascular disease, and metabolic disorders. This...0 Commentarii 0 Distribuiri 284 Views 0 previzualizare
-
Anti-Obesity Drugs Market Analysis: Emerging Therapies and ForecastThe Anti-obesity Drugs Market is moving toward a broader metabolic-health model in which medicines may address obesity alongside associated cardiovascular, sleep, liver, kidney, and other chronic conditions. Market Research Future estimates that the industry will increase from USD 24.5 billion in 2025 to USD 318.0 billion by 2035, creating substantial opportunities for pharmaceutical...0 Commentarii 0 Distribuiri 181 Views 0 previzualizare
-
Anti-Obesity Medication Market Size, Share, Growth, Trends & Forecast Report, 2025–2032According to the latest report published by Data Bridge Market Research, the Anti-Obesity Medication Market The global anti-obesity medication market size was valued at USD 8.71 billion in 2024 and is expected to reach USD 78.37 billion by 2032, at a CAGR of 31.60% during the forecast period Anti-Obesity Medication Market report, businesses...0 Commentarii 0 Distribuiri 732 Views 0 previzualizare
-
Anti-Obesity Medication Market Size,Trends And Analysis 2032According to the latest report published by Data Bridge Market Research, the Anti-Obesity Medication Market The global anti-obesity medication market size was valued at USD 8.71 billion in 2024 and is expected to reach USD 78.37 billion by 2032, at a CAGR of 31.60% during the forecast period The supreme Anti-Obesity Medication Market research...0 Commentarii 0 Distribuiri 159 Views 0 previzualizare
-
Anti-Obesity Medication Market: Key Factors Accelerating Adoption of Advanced TreatmentsPolaris Market Research presents its latest market research report, titled Anti-Obesity Medication Market. It is a comprehensive market research report analyzing the fast-evolving anti-obesity medication market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The study is a combination of...0 Commentarii 0 Distribuiri 93 Views 0 previzualizare
-
Asia Pacific Obesity Treatment Market Share, Demand & Industry Growth Report"Asia Pacific Obesity Treatment Market Summary According to the latest report published by Data Bridge Market Research, the Asia Pacific Obesity Treatment Market The Asia Pacific Obesity Treatment Market was valued at USD 5.09 million in 2024 and is expected to reach USD 16.72 Million by 2032 This Asia Pacific Obesity Treatment Market research report is generated with a...0 Commentarii 0 Distribuiri 363 Views 0 previzualizare
-
Bariatric Surgery Devices Market Driven by Rising Demand for Obesity Treatment SolutionsThe Bariatric Surgery Devices Market is experiencing sustained global growth as obesity and associated metabolic disorders continue to increase worldwide. Advances in minimally invasive surgical techniques, robotic-assisted platforms, powered stapling devices, and digital surgical planning are improving the safety, efficiency, and effectiveness of bariatric procedures. Rising healthcare...0 Commentarii 0 Distribuiri 243 Views 0 previzualizare
-
Diabetes & Obesity Treatment Trends in GLP-1 Agonists Market"Glucagon-Like Peptide 1 (GLP-1) Agonists Market Summary: According to the latest report published by Data Bridge Market Research, the Glucagon-Like Peptide 1 (GLP-1) Agonists Market The glucagon-like peptide 1 (GLP-1) agonists is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the glucagon-like peptide 1 (GLP-1) agonists market...0 Commentarii 0 Distribuiri 459 Views 0 previzualizare
-
Diacylglycerol O Acyltransferase 1 Market: Emerging Metabolic and Obesity TherapeuticsMarket Overview The Diacylglycerol O Acyltransferase 1 (DGAT1) market is gaining momentum as biopharmaceutical researchers investigate novel enzymatic pathways to treat metabolic disorders, obesity, non-alcoholic fatty liver disease (NAFLD/MASH), and type 2 diabetes. DGAT1 is a key enzyme involved in the final, rate-limiting step of triglyceride synthesis, catalyzing the conversion of...0 Commentarii 0 Distribuiri 111 Views 0 previzualizare
-
GLP-1 Agonists Weight Loss Drugs Market Growth as Tirzepatide Gains MomentumThe weight management industry is moving through a major shift as pharmaceutical treatments become an increasingly visible part of obesity care. GLP-1-based medicines have moved from being primarily associated with metabolic disease management to becoming a major category within weight loss treatment, supported by rising obesity prevalence, clinical efficacy, greater awareness, and expanding...0 Commentarii 0 Distribuiri 99 Views 0 previzualizare
-
Data Bridge Market Research analyses that the global smart airports market which was USD 2,620 million in 2022, is expected to reach USD 11,560 million by 2030, and is expected to undergo a CAGR of 16.1% during the forecast period of 2023 to 2030According to the latest report published by Data Bridge Market Research, the Smart Airports Market Data Bridge Market Research analyses that the global smart airports market which was USD 2,620 million in 2022, is expected to reach USD 11,560 million by 2030, and is expected to undergo a CAGR of 16.1% during the forecast period of 2023 to 2030 Smart Airports Market report...0 Commentarii 0 Distribuiri 177 Views 0 previzualizare
-
Europe Obesity Treatment Market Share Analysis, Trends & Forecast Report"Europe Obesity Treatment Market Summary According to the latest report published by Data Bridge Market Research, the Europe Obesity Treatment Market The Europe Obesity Treatment Market was valued at USD 7.48 Million in 2024 and is expected to reach USD 21.38 Million by 2032 This Europe Obesity Treatment Market research report is prepared with...0 Commentarii 0 Distribuiri 312 Views 0 previzualizare
-
Future Growth Prospects of the Anti-obesity Drugs Market 2035Although current incretin therapies have redefined weight management outcomes, pharmaceutical researchers are actively working to address remaining clinical challenges. Key areas of ongoing research include improving patient compliance through oral delivery, mitigating gastrointestinal side effects, and preserving lean muscle mass during active weight loss. The future landscape of the...0 Commentarii 0 Distribuiri 127 Views 0 previzualizare
-
Global Dual GIP/GLP-1 Receptor Agonists Obesity Drugs Market: Therapeutic Innovation, Obesity Treatment Trends, Demand, and Growth OutlookAccording to the latest report published by Data Bridge Market Research, the Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast...0 Commentarii 0 Distribuiri 194 Views 0 previzualizare
-
Hypothalamic Obesity Market Size, Share, Growth and Forecast 2026–2036NEWARK, Del., Aug. 21, 2026 — The global Hypothalamic Obesity Market is expanding as healthcare providers increasingly recognize the need for disease-specific treatment approaches for patients experiencing persistent weight gain following hypothalamic injury. According to Future Market Insights (FMI), the market is projected to grow from USD 1.1 billion in 2026 to USD 3.0 billion by 2036,...0 Commentarii 0 Distribuiri 98 Views 0 previzualizare
-
Lipase Inhibitors Obesity Drugs Market Accelerates with Growing Demand for Weight Management Therapies" According to the latest report published by Data Bridge Market Research, the Lipase Inhibitors Obesity Drugs Market CAGR Value The global lipase inhibitors obesity drugs market size was valued at USD 1.21 billion in 2024 and is expected to reach USD 3.61 billion by 2032, at a CAGR of 14.68% during the forecast period The large scale Lipase Inhibitors Obesity Drugs...0 Commentarii 0 Distribuiri 218 Views 0 previzualizare
-
Lipase Inhibitors Obesity Drugs Market Potential: Size, Share, Trends, and Future Outlook"Key Drivers Impacting Executive Summary Lipase Inhibitors Obesity Drugs Market Size and Share The global lipase inhibitors obesity drugs market size was valued at USD 1.21 billion in 2024 and is expected to reach USD 3.61 billion by 2032, at a CAGR of 14.68% during the forecast period The credible Lipase Inhibitors Obesity Drugs Marketreport comprises of various segments...0 Commentarii 0 Distribuiri 589 Views 0 previzualizare
Sponsorizeaza Paginile
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek
Bengali